About the Emerging Trends in Oncolytic Virus Therapy Session
Oncolytic virus therapy is an innovative cancer treatment that uses genetically modified viruses to selectively infect and kill cancer cells. These viruses are designed to replicate within tumor cells, causing cell lysis while sparing healthy cells. Additionally, oncolytic viruses can stimulate the immune system to recognize and attack cancer cells, providing an added therapeutic benefit. Emerging trends in oncolytic virus therapy focus on improving viral selectivity, enhancing immune responses, and combining the therapy with other cancer treatments, such as immune checkpoint inhibitors. This promising treatment has shown potential in clinical trials, with several viruses demonstrating efficacy against various types of cancer. Ongoing research aims to optimize these therapies and expand their clinical applications.
Topics Covered in Emerging Trends in Oncolytic Virus Therapy
Tumor-Selective Replication
Herpes & Adenovirus Vectors
Transgene-Armed Viruses
Immunogenic Cell Death
Checkpoint Combinations
Systemic Delivery Barriers
Related Scientific Sessions at CIOC 2027
Why Attend the Emerging Trends in Oncolytic Virus Therapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Emerging Trends in Oncolytic Virus Therapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Emerging Trends in Oncolytic Virus Therapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Emerging Trends in Oncolytic Virus Therapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Emerging Trends in Oncolytic Virus Therapy Conference 2027 — FAQs
What is the Emerging Trends in Oncolytic Virus Therapy track at CIOC 2027?
The Emerging Trends in Oncolytic Virus Therapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Emerging Trends in Oncolytic Virus Therapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Emerging Trends in Oncolytic Virus Therapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Emerging Trends in Oncolytic Virus Therapy are all welcome — whether presenting or attending.
Can I present my research in the Emerging Trends in Oncolytic Virus Therapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Emerging Trends in Oncolytic Virus Therapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Emerging Trends in Oncolytic Virus Therapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.